Organomodified nanoclay with boron compounds is improving structural and antibacterial properties of nanofibrous matrices
European Journal of Pharmaceutics and Biopharmaceutics · 2023-03 · 184 · 125-138
DOI: 10.1016/j.ejpb.2023.01.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2023-03. Verfasst von Sara Asghari Dilmani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Science and Engineering, Hacettepe University, Beytepe, Ankara, Turkey; Bioengineering Department, Hacettepe University, Beytepe, …. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Nanofibers. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 77 Literaturangaben.
Abstract (Originalsprache)
In this study, nanofibrous polymeric matrices were successfully developed with nanoclay, montmorillonite (MMT) and various boron (B) compounds, which were known to have positive effects on the wound healing with elevated antibacterial properties. For this purpose, MMT was modified with quaternary ammonium salt, trimethyl octadecyl ammonium bromide (TMOD), and boron compounds, boron nitride (BN), zinc borate (ZB), or phenylboronic acid (PBA) were adsorbed on organomodified MMT (OMMT). Then, poly (lactic acid) (PLA) based nanofibrous PLA-OMMT/B composites were fabricated via electrospinning. Modification of MMT nanoparticles with TMOD occurred through ion-exchange reaction and led to better homogenous fibrous structures which exhibited dramatic inhibition for gram-positive bacteria. Moreover, composites with ZB and PBA demonstrated both bacteriostatic and bactericidal effects for gram-positive and gram-negative bacteria. The chemical structures of the matrices were evaluated through ATR-FTIR and supported the intercalated composite formation. The thermal and mechanical stabilities of PLA matrices were also enhanced after OMMT and B incorporation. The lowest breaking strain value was recorded for PLA-OMMT/PBA composite compared to other B composites. The 100% and 50% extracts of the PLA-OMMT matrices showed modest cytotoxic effect on the human dermal fibroblasts (NHDF) on the second day culture that probably originated from TMOD. These results demonstrated that PLA-OMMT/B matrices, especially PBA including matrices, can be used as replaceable wound dressings that have limited interaction with cells but exhibit antibacterial activity and support the early stages of wound healing both morphologically and chemically.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Science and Engineering, Hacettepe University, Beytepe, Ankara, Turkey; Bioengineering Department, Hacettepe University, Beytepe, Ankara, Turkey.
- Graduate School of Science and Engineering, Hacettepe University, Beytepe, Ankara, Turkey; Chemical Engineering Department, Hacettepe University, Beytepe, Ankara, Turkey.
- Bioengineering Department, Hacettepe University, Beytepe, Ankara, Turkey; Chemical Engineering Department, Hacettepe University, Beytepe, Ankara, Turkey. Electronic address: menemse@hacettepe.edu.tr.
Zitieren
APA
Asghari Dilmani, S., Koç, S., Çakır, D., & Gümüşderelioğlu, M. (2023). Organomodified nanoclay with boron compounds is improving structural and antibacterial properties of nanofibrous matrices. European Journal of Pharmaceutics and Biopharmaceutics, 184, 125-138. https://doi.org/10.1016/j.ejpb.2023.01.015
Vancouver
Asghari Dilmani S, Koç S, Çakır D, Gümüşderelioğlu M. Organomodified nanoclay with boron compounds is improving structural and antibacterial properties of nanofibrous matrices. European Journal of Pharmaceutics and Biopharmaceutics. 2023;184:125-138. doi:10.1016/j.ejpb.2023.01.015
BibTeX
@article{AsghariDilmani2023,
author = {Asghari Dilmani, Sara and Koç, Sena and Çakır, Demet and Gümüşderelioğlu, Menemşe},
title = {Organomodified nanoclay with boron compounds is improving structural and antibacterial properties of nanofibrous matrices},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2023},
volume = {184},
pages = {125--138},
doi = {10.1016/j.ejpb.2023.01.015}
}
EUVIMED